SCHEMBL14928993

SCHEMBL14928993

CCCCC(OC(=O)c1ccc([N+](=O)[O-])cc1)C(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC2 Q92769 1/20 0.47
ADRB2 P07550 2/20 0.46
ADRB1 P08588 2/20 0.46
ADRB3 P13945 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
ATM Q13315 1/20 0.45
ALDH1A1 P00352 3/20 0.44
POLB P06746 2/20 0.44
MAPT P10636 3/20 0.43
ALOX12 P18054 1/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
MGLL Q99685 1/20 0.43
MAPK1 P28482 1/20 0.43
PKM P14618 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14928720 0.92 ADRB2 (0.48) HDAC3HDAC1HDAC2ADRB2ADRB1
SCHEMBL3370602 0.90 HDAC3 (0.45) HDAC3HDAC1HDAC2ADRB2ADRB1
SCHEMBL3688190 0.87 TSHR (0.47) ALDH1A1MAPTSLC6A2KMT2AMEN1
SCHEMBL25612582 0.86 HDAC3 (0.49) HDAC3HDAC1HDAC2ADRB2ADRB1
SCHEMBL14928965 0.86 ADRB2 (0.50) ADRB2ADRB1ADRB3L3MBTL1ATM
SCHEMBL17941247 0.83 ALDH1A1 (0.50) HDAC3HDAC1HDAC2ADRB2ADRB1
SCHEMBL14928772 0.82 MAPK1 (0.50) ADRB2ADRB1ADRB3L3MBTL1ATM
SCHEMBL3688191 0.82 MAPT (0.48) ALDH1A1MAPTMAPK1
SCHEMBL15081479 0.82 ADRB2 (0.46) HDAC3HDAC1HDAC2ADRB2ADRB1
SCHEMBL1142097 0.82 ALDH1A1 (0.52) HDAC3HDAC1HDAC2ADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9051310-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2015-06-09 US disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-20140309225-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2014-10-16 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK HDAC3 31/4885HDAC1 47/4885HDAC2 62/4885
US-20140309225-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, BTK, NOX4 HDAC3 78/4885HDAC1 45/4885HDAC2 108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.